Integrins-specific drugs for cancers
Category: Pharmaceutical and Medical Devices
Exhibitor: DEVELOPMENT OF INTEGRIN-SPECIFIC DRUGS AND PROTEINS FOR CELL THERAPY
Booth No: R713
Characteristic
Targeting ?v and ?5β1 integrins and VEGFR2
Inhibition of tumor growth and metastasis, for treatments of brain and pancreatic cancers
IP protection: US10508137B2, TWI563001B, AU2015305299B2, CN106714818B, KR102102789B1; 13 applications (BR, CA, IN, JP, MX, RU, SG, EPC, UK, CH, FR, DE, IT) were pending.
Indication: cancers
Other Products
Products you may be interested in
Highest Rated Products